A detailed history of Ae Wealth Management LLC transactions in Organon & Co. stock. As of the latest transaction made, Ae Wealth Management LLC holds 50,440 shares of OGN stock, worth $379,813. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,440
Previous 42,182 19.58%
Holding current value
$379,813
Previous $408,000 31.86%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$8.4 - $10.85 $69,367 - $89,599
8,258 Added 19.58%
50,440 $538,000
Q2 2025

Aug 06, 2025

SELL
$8.04 - $14.72 $1.01 Million - $1.85 Million
-125,350 Reduced 74.82%
42,182 $408,000
Q1 2025

May 06, 2025

BUY
$14.29 - $16.41 $235,442 - $270,371
16,476 Added 10.91%
167,532 $2.49 Million
Q4 2024

Feb 13, 2025

BUY
$14.44 - $18.83 $497,905 - $649,277
34,481 Added 29.58%
151,056 $2.25 Million
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $81,276 - $100,364
4,358 Added 3.88%
116,575 $2.23 Million
Q2 2024

Aug 12, 2024

BUY
$17.45 - $21.96 $1.65 Million - $2.08 Million
94,652 Added 538.87%
112,217 $2.32 Million
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $304,620 - $415,592
-22,106 Reduced 55.72%
17,565 $330,000
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $242,137 - $382,997
22,113 Added 125.94%
39,671 $572,000
Q3 2023

Oct 11, 2023

BUY
$16.59 - $23.77 $291,287 - $417,353
17,558 New
17,558 $304,000
Q2 2022

Aug 03, 2022

BUY
$31.66 - $38.9 $269,901 - $331,622
8,525 New
8,525 $288,000
Q1 2022

Apr 18, 2022

SELL
$30.45 - $39.36 $255,445 - $330,191
-8,389 Closed
0 $0
Q4 2021

Jan 20, 2022

SELL
$28.67 - $37.13 $11,238 - $14,554
-392 Reduced 4.46%
8,389 $255,000
Q3 2021

Nov 01, 2021

SELL
$28.63 - $35.64 $81,967 - $102,037
-2,863 Reduced 24.59%
8,781 $288,000
Q2 2021

Jul 21, 2021

BUY
$28.45 - $38.0 $331,271 - $442,472
11,644 New
11,644 $352,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.